Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 20,518 | Dovepress* | 14,027+ | 1,923 | 15,950 | |
| PubMed Central* | 6,491 | 978 | 7,469 | ||
| Totals | 20,518 | 2,901 | 23,419 | ||
| *Since 23 January 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar